Appropriate Dose Selection – How to Optimize Clinical Drug Development

Appropriate Dose Selection. How to Optimize Clinical Drug Development-1

J. Venitz, W. Sittner
Editors

2007

Cancer has become a chronic disease, often requiring long-term, chronic oncological drug treatment. As a result, the oncological treatment is exposed to a large number of patients who may be on concurrent treatments for other health conditions and/or who may suffer from concomitant illnesses, both of which may affect the efficacy and safety of the oncological treatment by contributing to the increased incidence of adverse events and/or loss of efficacy.

Leave a Reply

Your email address will not be published. Required fields are marked *